-
1 Comment
MeVis Medical Solutions AG is currently in a long term uptrend where the price is trading 3.0% above its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.4.
MeVis Medical Solutions AG's total revenue sank by 0.0% to $5M since the same quarter in the previous year.
Its net income has dropped by 0.0% to $2M since the same quarter in the previous year.
Finally, its free cash flow fell by 0.0% to $1M since the same quarter in the previous year.
Based on the above factors, MeVis Medical Solutions AG gets an overall score of 2/5.
| Exchange | F |
|---|---|
| CurrencyCode | EUR |
| ISIN | DE000A0LBFE4 |
| Sector | Healthcare |
| Industry | Health Information Services |
| Market Cap | 47M |
|---|---|
| PE Ratio | 0.0 |
| Target Price | 38 |
| Dividend Yield | 4.0% |
| Beta | -0.1 |
MeVis Medical Solutions AG develops, markets, and sells software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company's clinical focuses are image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological diseases. It offers X-ray based radiography procedures, including computed tomography, mammography/digital tomosynthesis, magnetic resonance imaging, and digital sonography; and provides services in the field of software programming for medical technology companies, which comprise provision of software developers, product and project managers, application specialists, and test engineers. The company also offers three-dimensional technical visualizations; and interactive online training to enhance the diagnostic skills of clinicians, as well as internet-based special applications in teleradiology. In addition, it develops and sells software licenses; and provides services for technical visualization and online training. The company was incorporated in 1997 and is based in Bremen, Germany. MeVis Medical Solutions AG is a subsidiary of Varex Imaging Corporation.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for M3V.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
